Chemoradiation for Unresectable Gall Bladder Cancer: Time to Review Historic Nihilism?

Reena Engineer(Tata Memorial Hospital), Shyam Kishore Shrivastava(HCG Cancer Centre), Venkatesh Rangarajan(Tata Memorial Hospital), Umesh Mahantshetty(Homi Bhabha National Institute), Tabassum Wadasadawala(Homi Bhabha National Institute), Shaesta Mehta(Tata Memorial Hospital), Nilendu Purandare(Tata Memorial Hospital)
Journal of Gastrointestinal Cancer
August 27, 2010
10.1007/s12029-010-9179-3
Cited by 17

Related Papers

The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
|The Lancet Oncology|2021|624
Dose–volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study
|Radiotherapy and Oncology|2016|266
Dose–effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study
|Radiotherapy and Oncology|2016|214